학술논문

Marstacimab, a tissue factor pathway inhibitor neutralizing antibody, improves coagulation parameters of ex vivo dosed haemophilic blood and plasmas
Document Type
Article
Source
In: Haemophilia. (Haemophilia, 1 September 2019, 25(5):797-806)
Subject
Language
English
ISSN
13652516
13518216